Biggest News Aggregation in the World
๐Ÿ“ฐ Alkermes News

Page 39 - Alkermes News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.

Alkermes (NASDAQ:ALKS) Shares Up 3.4% on Analyst Upgrade

Alkermes plc (NASDAQ:ALKS – Get Rating)’s share price traded up 3.4% on Tuesday after JPMorgan Chase & Co. raised their price target on the stock from $29.00 to $31.00. The stock traded as high as $30.27 and last traded at $30.18. 1,538,199 shares traded hands during trading, an increase of 18% from the average session […]
United States Stifel Nicolaus Alkermes Company Profile Eversource Wealth Advisors China Universal Asset Management Co Lazard Asset Management
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

ALKERMES PLC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure. On April 25, 2023, Alkermes plc issued a press release related to the matter described in this Current Report on Form 8-K, a copy of which is furnished herewith... | April 25, 2023
United States Securities Exchange Exchange Commission Institute For Conflict Prevention Company Annual Report On Form Current Report

Restricted Indication for Maintenance Niraparib Therapy in Recurrent Ovarian Cancer Further Supported by Final Survival Analysis of NOVA Trial

Ursula A. Matulonis highlights previous data from the phase 3 ENGOT-OV16/NOVA trial initial readout and subsequent preplanned overall survival analysis, discusses new findings from the final analysis, and emphasizes how these data clarify some of the studyโ€™s limitations and reinforce the importance of adhering to the adjusted FDA label for niraparib in recurrent ovarian cancer.
Dana Farber Cancer Institute United States Ursulaa Matulonis Boehringer Ingelheim Division Of Gynecologic Oncology Harvard Medical School

Profund Advisors LLC Has $581,000 Holdings in Alkermes plc (NASDAQ:ALKS)

Profund Advisors LLC grew its stake in Alkermes plc (NASDAQ:ALKS – Get Rating) by 2.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,216 shares of the company’s stock after purchasing an additional 437 shares during the period. Profund Advisors LLC’s holdings […]
United States Stifel Nicolaus Jupiter Asset Management Ltd Alkermes Company Profile Alkermes Plc Profund Advisors

Alkermes Announces Application Period for 2023 Alkermes Inspiration Grants® Program To Support Innovative Initiatives Focused on People Affected by Addiction, Serious Mental Illness or Cancer

DUBLIN / ACCESSWIRE / April 21, 2023 / Alkermes plc (Nasdaq:ALKS) recently announced that the company will accept applications for its Alkermes Inspiration Grants® program beginning on May 1, 2023. Now
United States Alkermes Inc Alkermes Inspiration Richard Pops Chief Executive Officer Alkermes Inspiration Grants

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science